Myriad Genetics Inc financial data

Symbol
MYGN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
322 North 2200 West, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 196 % +27.4%
Quick Ratio 16.3 % +29.8%
Debt-to-equity 46.7 % -6.3%
Return On Equity -12.1 % -313%
Return On Assets -10.5 % +55%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91M shares +10.8%
Common Stock, Shares, Outstanding 91M shares +10.8%
Entity Public Float 1.9B USD +29.5%
Common Stock, Value, Issued 900K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 90.9M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 90.9M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 824M USD +12.1%
Research and Development Expense 102M USD +11.4%
Costs and Expenses 939M USD -7.23%
Operating Income (Loss) -116M USD +58.4%
Nonoperating Income (Expense) -800K USD +78.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -117M USD +58.7%
Income Tax Expense (Benefit) -600K USD +92.1%
Net Income (Loss) Attributable to Parent -116M USD +57.7%
Earnings Per Share, Basic -1.28 USD/shares +61.9%
Earnings Per Share, Diluted -1.28 USD/shares +61.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99.9M USD +31.4%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 141M USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current 126M USD +9.12%
Inventory, Net 26.2M USD +4.38%
Assets, Current 293M USD +10.5%
Property, Plant and Equipment, Net 115M USD -4.39%
Operating Lease, Right-of-Use Asset 57.4M USD -44.8%
Intangible Assets, Net (Excluding Goodwill) 313M USD -12.4%
Goodwill 286M USD -0.11%
Other Assets, Noncurrent 16.5M USD +4.43%
Assets 1.08B USD -5.9%
Accounts Payable, Current 29.6M USD -12.7%
Employee-related Liabilities, Current 51.4M USD +9.36%
Accrued Liabilities, Current 111M USD -29.4%
Contract with Customer, Liability, Current 500K USD -16.7%
Liabilities, Current 154M USD -26.3%
Deferred Income Tax Liabilities, Net 2.7M USD -74.3%
Operating Lease, Liability, Noncurrent 90.6M USD -37.6%
Other Liabilities, Noncurrent 34.3M USD -15.3%
Liabilities 350M USD -24.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -100K USD +98.1%
Retained Earnings (Accumulated Deficit) -714M USD -19.4%
Stockholders' Equity Attributable to Parent 732M USD +7.07%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 886M USD -8.47%
Liabilities and Equity 1.08B USD -5.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +44%
Net Cash Provided by (Used in) Financing Activities -8.8M USD -79.6%
Net Cash Provided by (Used in) Investing Activities -7.1M USD -121%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 91M shares +10.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -35.3M USD -970%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 110M USD +29.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD
Deferred Tax Assets, Valuation Allowance 95M USD +124%
Deferred Tax Assets, Gross 195M USD +21.2%
Depreciation 18.6M USD +3.91%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -112M USD +58.2%
Lessee, Operating Lease, Liability, to be Paid 161M USD -13.2%
Property, Plant and Equipment, Gross 233M USD -2.6%
Operating Lease, Liability, Current 13.5M USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.9M USD -24.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.5M USD +11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47.6M USD +152%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.6M USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 77.1M USD +15.8%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 48.1M USD +9.57%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.7M USD -28.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 42.7M USD +0.47%
Deferred Tax Assets, Net of Valuation Allowance 100M USD -15.6%
Share-based Payment Arrangement, Expense 9.4M USD -6%
Interest Expense 2.9M USD +3.57%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%